Medical Technology - G20

The projected revenue for the Medical Technology market market in G20 is estimated to reach US$481.70bn in 2024.
Among the various markets within the market, the largest market share belongs to Medical Devices, which is projected to have a market volume of US$411.60bn in the same year.
Looking ahead, the market is expected to experience an annual growth rate of 5.00% from 2024 to 2029 (CAGR 2024-2029), resulting in a market volume of US$614.80bn by 2029.
When compared globally, it is anticipated that the United States will generate the highest revenue, with an estimated figure of US$210.00bn in 2024.
The Medical Technology market market is an important market within the in G20 countries, encompassing a wide range of innovative healthcare products and services.
In the G20 country of Germany, the current trend in the Medical Technology market is the increasing use of artificial intelligence in diagnostic and treatment processes.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in G20 is experiencing significant growth and development due to several key factors. Customer preferences for advanced healthcare solutions, increasing demand for medical devices, and local special circumstances are driving the growth of this market. Additionally, underlying macroeconomic factors such as rising healthcare expenditure and technological advancements are also contributing to the expansion of the Medical Technology market in G20. Customer preferences in the G20 countries are shifting towards advanced healthcare solutions and medical devices. With an aging population and increasing awareness about healthcare, customers are seeking innovative and efficient medical technologies that can improve patient outcomes and quality of life. This has led to a surge in demand for medical devices such as diagnostic equipment, surgical instruments, and implantable devices. Trends in the market vary across G20 countries, reflecting the diverse healthcare systems and regulatory environments. In developed countries such as the United States, Germany, and Japan, the market is characterized by a high level of technological sophistication and a focus on research and development. These countries are at the forefront of medical innovation and are driving advancements in areas such as precision medicine, telemedicine, and artificial intelligence. In emerging economies such as China, India, and Brazil, the Medical Technology market is experiencing rapid growth due to increasing healthcare spending and improving healthcare infrastructure. These countries are investing heavily in healthcare reforms and are expanding access to medical services, leading to a greater demand for medical devices and technologies. Local special circumstances also play a role in shaping the Medical Technology market in G20. For example, in countries with universal healthcare systems such as Canada and the United Kingdom, government regulations and reimbursement policies have a significant impact on the adoption and usage of medical technologies. In countries with a strong private healthcare sector, such as the United States, market dynamics are influenced by factors such as insurance coverage and patient affordability. Underlying macroeconomic factors, such as rising healthcare expenditure and technological advancements, are driving the growth of the Medical Technology market in G20. Governments across G20 countries are increasing their healthcare budgets to address the growing healthcare needs of their populations. This increased spending is fueling the demand for medical technologies and driving market growth. Technological advancements in areas such as robotics, genomics, and digital health are also driving the growth of the Medical Technology market. These advancements are enabling the development of innovative medical devices and solutions that are more accurate, efficient, and patient-friendly. In conclusion, the Medical Technology market in G20 is experiencing significant growth and development due to customer preferences for advanced healthcare solutions, increasing demand for medical devices, local special circumstances, and underlying macroeconomic factors. As healthcare needs continue to evolve and technology continues to advance, the Medical Technology market in G20 is expected to continue its upward trajectory.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.